OCULOPHARYNGEAL MUSCULAR DYSTROPHY
Clinical trials for OCULOPHARYNGEAL MUSCULAR DYSTROPHY explained in plain language.
Never miss a new study
Get alerted when new OCULOPHARYNGEAL MUSCULAR DYSTROPHY trials appear
Sign up with your email to follow new studies for OCULOPHARYNGEAL MUSCULAR DYSTROPHY, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New injection aims to restore swallowing in rare muscle disease
Disease control Recruiting nowThis study tests a single injection of BB-301 directly into throat muscles to improve swallowing in people with oculopharyngeal muscular dystrophy (OPMD). About 30 adults aged 50-65 with swallowing problems will receive the injection during a short surgery. Researchers will check…
Matched conditions: OCULOPHARYNGEAL MUSCULAR DYSTROPHY
Phase: PHASE1, PHASE2 • Sponsor: Benitec Biopharma, Inc. • Aim: Disease control
Last updated Jun 27, 2026 08:07 UTC
-
Spit test may reveal clues about rare muscle disease
Knowledge-focused Recruiting nowThis observational study looks at saliva thickness and oral health in people with Oculopharyngeal Muscular Dystrophy (OPMD) compared to their household members. Researchers want to see if swallowing problems affect oral health and if saliva contains markers of the disease. No tre…
Matched conditions: OCULOPHARYNGEAL MUSCULAR DYSTROPHY
Sponsor: Sheba Medical Center • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:00 UTC